N/A
Completed N=31
Investigation Into the Effects of Blood Glucose Levels Upon Eating Behavior in Lean and Obese Non-diabetic and Diabetic Subjects
Source: ClinicalTrials.gov NCT02673203 ↗Enrolled (actual)
31
Serious AEs
0.0%
Results posted
Jan 2020
Primary outcomePrimary: Rate of Changing Glucose Level — 0.52; 0.44 mg/dl/min
Summary
To investigate whether the daily glucose profiles as assessed by continuous glucose monitoring for 1 week of normal weight and obese individuals relate to hunger levels and food intake.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Rate of Changing Glucose Level |
0.52; 0.44 | — |
| PRIMARY Glucose Peak |
119.5; 121.5 | — |
| PRIMARY Glucose Nadir |
85.1; 87.1 | — |
| SECONDARY Difference in Glucose Peak and Nadir |
34.3; 33.9 | — |
| SECONDARY Average Daily Hunger Rating |
5.8; 5.6 | — |
| SECONDARY Nutirion Intake: Energy |
2251.5; 2167.8 | — |
| SECONDARY Nutirion Intake: Carbohydrate |
261.1; 251.8 | — |
| SECONDARY Nutirion Intake: Fat |
92.4; 97.5 | — |
| SECONDARY Nutirion Intake: Protein |
99.9; 80.9 | — |
Eligibility Criteria
Inclusion Criteria
- A1c 1.5 mg/dL,
- Hgb 2.5 X ULN,
- untreated thyroid disease,
- uncontrolled hypertension,
- known neurological disorders,
- untreated psychiatric disorders,
- use of antidepressants and psychiatric medications,
- use of weight loss medications in the 6 months prior to the study,
- malignancy,
- smoking,
- current or recent steroid use in last 3 months,
- history of current illicit drug use;
- for women: pregnancy, or breastfeeding.
Data sourced from ClinicalTrials.gov (NCT02673203). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.